GSK (GSK) announced that new drug applications have been accepted for review by the China National Medical Products Administration and ...

GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...

Teva Pharmaceutical Industries Ltd. ADR 0.46% $24.53B ...

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...

With a marching band, NFL cheerleaders and costumed Mardi Gras krewe members, New Orleans unveiled a new brand for its Louis ...

GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of phase 3 trials presented at the European Respiratory Society (ERS ...

The Goldsmiths' Company has unveiled a striking new visual identity, updating its rich heritage for a fresh contemporary ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.